Janus Henderson Group
APLT

Janus Henderson Group’s Applied Therapeutics APLT Stock Holding History

Janus Henderson Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35,791
Closed -$30.8K – 2486
2024
Q4 		$30.8K Sell
35,791
-10,505,737
-100% -$65.9M ﹤0.01% 2522
2024
Q3 		$89.7M Buy
10,541,528
+2,893,323
+38% +$17.1M 0.05% 292
2024
Q2 		$35.5M Buy
7,648,205
+1,233,563
+19% +$5.84M 0.02% 450
2024
Q1 		$43.6M Buy
6,414,642
+4,266,179
+199% +$19.2M 0.02% 417
2023
Q4 		$7.19M Buy
+2,148,463
New +$5.35M ﹤0.01% 723

Other funds holding APLT

VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Janus Henderson Group's APLT Position: Q1 2025 in Review

Janus Henderson Group sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 35,791 shares — an estimated $30.8K sold.

Janus Henderson Group first reported a position in APLT in Q4 2023 and held it in 5 quarters. The position peaked at $89.7M in Q3 2024. 90 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • Janus Henderson Group reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 35,791 Applied Therapeutics shares in Q1 2025, an estimated $30.8K.
  • Janus Henderson Group first reported a position in Applied Therapeutics in Q4 2023 and held it in 5 quarters.
  • Janus Henderson Group's Applied Therapeutics position peaked at $89.7M in Q3 2024.
  • 90 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.